These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15885893)

  • 41. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling.
    Mustonen E; Ruskoaho H; Rysä J
    Ann Med; 2012 Dec; 44(8):793-804. PubMed ID: 22380695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular characterization of the canine cytokine TWEAK (CD255) and its receptor, Fn14 (CD266).
    Zhang JX; Sang M; Zhao W; Ai HX; Shui Y; Li JF; Song R; Zhang SQ
    Vet Immunol Immunopathol; 2010 Sep; 137(1-2):172-5. PubMed ID: 20452679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
    Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
    J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration.
    Liu YP; Yuan CM; Zhang SG; Hao QH; Wang MM; Zhang Z; Meng Q; Li M; Hao YD
    Histol Histopathol; 2016 Sep; 31(9):943-8. PubMed ID: 26907852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.
    Benicchi T; Iozzi S; Svahn A; Axelsson H; Mori E; Bernocco S; Cappelli F; Caramelli C; Fanti P; Genesio E; Maccari L; Markova N; Micco I; Porcari V; Schultz J; Fecke W
    J Biomol Screen; 2012 Aug; 17(7):933-45. PubMed ID: 22644269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
    Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tweak induces mammary epithelial branching morphogenesis.
    Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
    Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine cooperation in renal tubular cell injury: the role of TWEAK.
    Justo P; Sanz AB; Sanchez-Niño MD; Winkles JA; Lorz C; Egido J; Ortiz A
    Kidney Int; 2006 Nov; 70(10):1750-8. PubMed ID: 17003819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TWEAK/Fn14 signaling in tumors.
    Hu G; Zeng W; Xia Y
    Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.
    Burkly LC
    Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular structure and characterization of the cytokine TWEAK and its receptor Fn14 in bovine.
    Zhang JX; Sang M; Li JF; Zhao W; Ma HW; Min C; Hu YL; Du MX; Zhang SQ
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):238-46. PubMed ID: 21955444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
    Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
    Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
    Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
    Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-kappaB pathway.
    Brown SA; Ghosh A; Winkles JA
    J Biol Chem; 2010 Jun; 285(23):17432-41. PubMed ID: 20385556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.